“Nanotechnology Based Drug Delivery System Of Rivastigmine For The Treatment Of Alzheimer’s Disease”. 2022. Journal of Pharmaceutical Negative Results, January, 2532-41. https://doi.org/10.47750/pnr.2022.13.S01.298.